Medications
Startup wants to bring back Vioxx for hemophilia joint pain
Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so.
Nov 21, 2017
0
0
Hemophilia
Medications
FDA OKs new therapy for some hemophilia patients
U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.
Nov 16, 2017
0
0
Genetics
US scientists try first gene editing in the body
Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person's DNA to try to cure a disease.
Nov 15, 2017
3
1117
Medical research
Disruptive technology for the treatment of hemophilia
An international team of hematologists including Guy Young, MD, of Children's Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel therapy called emicizumab, decreases incidence of bleeding ...
Jul 10, 2017
0
22
Genetics
Researchers improve vbectors for delivering hFVIII gene therapy to treat Hemophilia A
A new study examined 42 combinations of promoters and enhancers for human factor VIII (hFVIII) gene expression to identify the optimal adeno-associated virus (AAV)-based gene therapy delivery vector constructs to take forward ...
Mar 31, 2017
0
0
Medical research
Researchers develop potential oral treatment for hemophilia
(HealthDay)—People with hemophilia have to endure painful injections every few days to stay alive, but a newly developed treatment may one day offer a simpler, cheaper and less painful alternative.
Dec 29, 2016
0
0
Medical research
To treat one rare blood disorder, scientists exploit another
For the nearly 400,000 individuals around the world with hemophilia A and hemophilia B—rare blood disorders that impair a person's ability to form clots to stop bleeding—relief may someday come from a treatment with similarities ...
Oct 27, 2016
0
0
Medical research
In crafting new treatments for hemophilia, a 'less is more' approach
Hematology researchers have found that blocking the role of a common protein may offer unexpected benefits for patients with the inherited bleeding disorder hemophilia A. The finding offers potential for developing both gene ...
Oct 17, 2016
0
0
Medications
Direct-to-consumer marketing to people with hemophilia
The manner in which pharmaceutical companies market their products to people who have hemophilia appears unprecedented and direct-to-consumer marketing should be examined by regulators, say researchers who reviewed documents, ...
Jun 14, 2016
0
0
Medical research
Study suggests another look at common treatments for hemophilia
Families of children with severe hemophilia A may want to take a fresh look at treatment options from human plasma. A study published in the New England Journal of Medicine on May 26 showed that participants who received ...
Jun 13, 2016
0
1
